▲ Peaking
Business
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Merck and Moderna’s melanoma vaccine hits key survival milestones, sending Moderna's stock soaring.
Interpath-001
1 trends tracked about this subject — the full history, oldest to newest below.